Adverse Drug Reaction News Bulletins
ADR News Bulletin 2022 December (Volume 24 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
21 December 2022
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Topical corticosteroids and risk of topical steroid withdrawal
Updates on adulterated products reported to HSA
Janus Kinase (JAK) inhibitors and risk of major adverse cardiovascular events, malignancy, thrombosis and death
AE Case in Focus 1: Test Yourself – What is the likely cause of the neurological symptoms in these patients?
AE Case in Focus 2: Test Yourself – What could have caused this patient’s presentation?
Click on the link below to download the issue in pdf:
